Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage.

Autor: Suárez EU; Department of Hematology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain. uriel.suarez@udea.edu.co., Piris MÁ; Department of Pathology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain., Rodríguez-Pinilla SM; Department of Pathology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain., García JF; Department of Pathology, MD Anderson Cancer Center, Madrid, Spain., López-Lorenzo JL; Department of Hematology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain., Cornago-Navascués J; Department of Hematology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain., Salgado-Sánchez R; Department of Hematology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain., Castaño-Bonilla T; Department of Hematology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain., Mata-Serna R; Department of Hematology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain., Alonso-Domínguez JM; Department of Hematology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain., Llamas P; Department of Hematology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.
Jazyk: angličtina
Zdroj: Annals of hematology [Ann Hematol] 2024 May; Vol. 103 (5), pp. 1797-1799. Date of Electronic Publication: 2024 Feb 03.
DOI: 10.1007/s00277-024-05647-6
Databáze: MEDLINE